Chandra Bhagat Pharma Limited (BOM:542934)
India flag India · Delayed Price · Currency is INR
63.00
+3.00 (5.00%)
At close: Nov 16, 2026

Chandra Bhagat Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,7391,168908.562,2251,197940.76
Revenue Growth
48.89%28.53%-59.17%85.93%27.21%33.07%
Gross Profit
272.36230.86173.75142.31129.04126.34
Operating Income
68.5437.0922.2431.6936.6651.17
Net Income
54.5930.468.5815.39.057.97
Earnings Per Share
7.274.041.142.031.201.06
EPS Growth
80.12%255.11%-43.95%69.02%13.64%322.37%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
22.2747.798.0250.9765.4959.03
Total Debt
150.53165.07208.6164.27189.45211.18
Net Cash (Debt)
-128.27-117.28-200.58-113.3-123.95-152.15
Net Cash Growth
------
Net Cash Per Share
-17.09-15.54-26.58-15.02-16.43-20.17

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
63.0192.36-57.0961.7652.64123.98
Capital Expenditures
-28.07-9.21-12.03-22.82-3.69-1
Free Cash Flow
34.9483.15-69.1138.9448.96122.99
Free Cash Flow Growth
-57.98%---20.46%-60.19%48.03%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
15.66%19.77%19.12%6.40%10.78%13.43%
Operating Margin
3.94%3.18%2.45%1.42%3.06%5.44%
Pretax Margin
4.30%3.65%1.32%1.15%1.18%1.17%
Profit Margin
3.14%2.61%0.94%0.69%0.76%0.85%
FCF Margin
2.01%7.12%-7.61%1.75%4.09%13.07%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
8.257.5646.0346.8480.83107.77
P/FCF Ratio
12.962.77-18.4114.956.98
PS Ratio
0.260.200.440.320.610.91